Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 1 sale; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Boundless Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 55 | 2 | 54 | +1 |
| Shares | 13.0M | 1.25M | 17.0M | +5.26M (+44.9%) |
| Value | $37.6M | $3.62M | $19.6M | −$14.3M (−42.2%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Boundless Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nextech Invest, Ltd. | 1,228,069 | $1.85M | 0.43% |
| XTX Topco Ltd | 25,917 | $39.1K | 0.00% |
| Susquehanna International Group, LLP | 23,243 | $35.1K | 0.00% |
| Bank of New York Mellon Corp | 15,360 | $23.2K | 0.00% |
| Renaissance Technologies LLC | 14,400 | $21.7K | 0.00% |
| Intech Investment Management LLC | 11,809 | $17.8K | 0.00% |
| True Wealth Design, LLC | 5 | $8 | 0.00% |
| EverSource Wealth Advisors, LLC | 3 | $5 | 0.00% |
| Nuveen, LLC | 3,958,413 | – | – |
Sold out (8)
Institutions that held Boundless Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| UBS Oconnor LLC | 140,000 | $406.0K |
| Bridgeway Capital Management, LLC | 50,000 | $145.0K |
| Squarepoint Ops LLC | 32,182 | $93.3K |
| Two Sigma Investments, LP | 13,808 | $40.0K |
| Verition Fund Management LLC | 11,665 | $33.8K |
| SG Americas Securities, LLC | 10,753 | $31.0K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 122 | $353 |
| Deutsche Bank AG | 97 | $281 |
Not filed for Q1 2025 yet (2)
Institutions that held Boundless Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nextech Invest AG | 1,228,069 | $3.56M |
| Nuveen Asset Management, LLC | 21,523 | $62.4K |